Effect of Different Expression of Immune-Related lncRNA on Colon Adenocarcinoma and Its Relation to Prognosis

Abstract EN

Objective.

To explore the expression of immune-related lncRNAs in colon adenocarcinoma and find out the effect on how these lncRNAs influence the development and prognosis of colon adenocarcinoma.

Method.

Transcriptome data of colon adenocarcinoma from The Cancer Genome Atlas (TCGA) were downloaded, and gene sets “IMMUNE RESPONSE” and “IMMUNE SYSTEM PROCESS” were sought from the Molecular Signatures Database (MSigDB).

The expression of immune-related genes was extracted that were immune-related mRNAs.

Then, the immune-related lncRNAs were sought out by utilizing of the above data.

Clinical traits were combined with immune-related lncRNAs, so that prognostic-related lncRNAs were identified by Cox regression.

Multivariate Cox regression was built to calculate risk scores.

Relationships between clinical traits and immune-related lncRNAs were also calculated.

Result.

A total of 480 colorectal adenocarcinoma patients and 41 normal control patients’ transcriptome sequencing data of tissue samples were obtained from TCGA database.

918 immune-related lncRNAs were screened.

Cox regression showed that 34 immune-related lncRNAs were associated with colon adenocarcinoma prognosis.

Seven lncRNAs were independent risk factors.

Conclusion.

This study revealed that some lncRNAs can affect the development and prognosis of colon adenocarcinoma.

It may provide new theory evidence of molecular mechanism for the future research and molecular targeted therapy of colon adenocarcinoma.